Concepedia

Mark Landers

ML

Statistics

Publications

19

Citations

2K

H-Index

16

Active since

1993

Affiliations

Epic Sciences (United States)(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

UConn Health

Mark Landers is an author at Epic Sciences (United States) specializing in medicine, oncology, and circulating tumor cell characterization.

Publications per year

1993–2020

19

Publications

19

Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein

Anne-Marie B. Brillantes, Karol Ondriaš, Andrew Scott et al. · Cell · 1994 · 817 citations

, , +16

Regulation of the large ( 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn

Mark Landers · Nucleic Acids Research · 2004 · 152 citations · Full text

, , +16

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · Cancer Research · 2017 · 135 citations

, , +17

The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer

Himisha Beltran, Adam Jendrisak, Mark Landers et al. · Clinical Cancer Research · 2015 · 134 citations · Full text

, , +17

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Shannon L. Werner, Ryon P. Graf, Mark Landers et al. · Journal of Circulating Biomarkers · 2015 · 127 citations · Full text

, , +2

1–5 of 19